Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma.
Fraterman I, Reijers ILM, Dimitriadis P, Broeks A, Gonzalez M, Menzies AMM, Lopez-Yurda M, Kapiteijn E, van der Veldt AAM, Suijkerbuijk KPM, Hospers GAP, Long GV, Blank CU, van de Poll-Franse LV. Fraterman I, et al. Among authors: suijkerbuijk kpm. Nat Med. 2023 Dec;29(12):3090-3099. doi: 10.1038/s41591-023-02631-x. Epub 2023 Nov 13. Nat Med. 2023. PMID: 37957378
Oxytocin: bringing magic into nipple aspiration.
Suijkerbuijk KP, van der Wall E, van Diest PJ. Suijkerbuijk KP, et al. Ann Oncol. 2007 Oct;18(10):1743-4. doi: 10.1093/annonc/mdm435. Epub 2007 Sep 4. Ann Oncol. 2007. PMID: 17785758 Free article. No abstract available.
Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1-10 brain metastases treated with stereotactic radiosurgery.
Nagtegaal SHJ, Claes A, Suijkerbuijk KPM, Schramel FMNH, Snijders TJ, Verhoeff JJC. Nagtegaal SHJ, et al. Among authors: suijkerbuijk kpm. Radiother Oncol. 2019 Sep;138:173-179. doi: 10.1016/j.radonc.2019.06.033. Epub 2019 Jul 11. Radiother Oncol. 2019. PMID: 31302392
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.
Larkin J, Chmielowski B, Lao CD, Hodi FS, Sharfman W, Weber J, Suijkerbuijk KPM, Azevedo S, Li H, Reshef D, Avila A, Reardon DA. Larkin J, et al. Among authors: suijkerbuijk kpm. Oncologist. 2017 Jun;22(6):709-718. doi: 10.1634/theoncologist.2016-0487. Epub 2017 May 11. Oncologist. 2017. PMID: 28495807 Free PMC article.
123 results